Back
Phillips 66 Vs. Travere Therapeutics, Inc. Industry Stock Comparison
Sell
25
PSX
Phillips 66
Last Price:
$127.75
Seasonality Move:
4.44%
Buy
78
TVTX
Travere Therapeutics, Inc.
Last Price:
$39.6600
Seasonality Move:
33.23%
Sell
25
Phillips 66 (PSX)
is a Sell
Is Phillips 66 a Buy, Sell or Hold?
-
The current Phillips 66 [PSX] share price is $127.75. The Score for PSX is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
-
PSX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
78
Travere Therapeutics, Inc. (TVTX)
is a Buy
Is Travere Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Travere Therapeutics, Inc. [TVTX] share price is $39.6400. The Score for TVTX is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
-
TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PSX Stock Price Chart
What is Phillips 66's stock price today?
-
The Phillips 66 share price today is $127.75Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PSX is experiencing selling pressure, which indicates risk of future bearish movement.
TVTX Stock Price Chart
What is Travere Therapeutics, Inc.'s stock price today?
-
The Travere Therapeutics, Inc. share price today is $39.6400Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight selling pressure.
PSX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 35.11 | Buy |
| Relative Strength Index (14 RSI): | 33.56 | Sell |
| Chaikin Money Flow: | -690375 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (130.4 - 140.48) | Sell |
| Bollinger Bands (100): | (127.02 - 138.34) | Sell |
TVTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 10.28 | Buy |
| Relative Strength Index (14 RSI): | 66.31 | Buy |
| Chaikin Money Flow: | -583105 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.9202 - 36.9202) | Buy |
| Bollinger Bands (100): | (20.9405 - 34.5405) | Buy |
PSX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 129.51 | Sell |
| 20-day SMA: | 135.91 | Sell |
| 50-day SMA: | 135.6 | Sell |
| 200-day SMA: | 125.05 | Buy |
| 8-day EMA: | 106.57 | Buy |
| 20-day EMA: | 64.97 | Buy |
| 50-day EMA: | 31.53 | Buy |
| 200-day EMA: | 8.73 | Buy |
TVTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.31 | Buy |
| 20-day SMA: | 35.4 | Buy |
| 50-day SMA: | 33.69 | Buy |
| 200-day SMA: | 22.3 | Buy |
| 8-day EMA: | 30.99 | Buy |
| 20-day EMA: | 18.54 | Buy |
| 50-day EMA: | 8.93 | Buy |
| 200-day EMA: | 2.46 | Buy |
Phillips 66 Earnings Growth & PSX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.25 per share, and an increase next year of $5.17 per share.
Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.
Phillips 66 Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Travere Therapeutics, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||